TrialAssure Gains Data Science Leader to Advance Clinical AI Strategy
Canton, MI — December 2, 2025 — TrialAssure, a global leader in clinical trial transparency, disclosure, and data-sharing technology,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Canton, MI — December 2, 2025 — TrialAssure, a global leader in clinical trial transparency, disclosure, and data-sharing technology,...
Dover, DE — December 2, 2025 — PumasAI announced that its secure scientific AI assistant, AskPumas, has officially surpassed...
